Fundraising Fox
/People
Sign in

Susan Hill

Chief Executive Officer at Mestag

Cambridge, England, United Kingdom

Find your path to Susan

319 people in our graph can introduce you to Susan.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Dominic Schmidt to introduce you to Susan

You →Dominic · together at Spur Therapeutics (2016–2017) →Susan

Ask Jamie Chen to introduce you to Susan

You →Jamie · 3 people · together at Mestag →Susan

Ask Sam Okafor to introduce you to Susan

You →Sam · 8 people · together at Merck Healthcare →Susan

Sign up to find every way you can get introduced to Susan

  • Your email: the people you already email who know Susan
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Susan
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up free →Already have an account? Log in

Chief Executive Officer at Mestag

Intro paths

→

In turn, Susan can intro founders to Mestag's investors below.

Mestag's investors · 6

ForbionNaarden · since 2026GV (Google Ventures)Mountain View · $250K – $50M checks · since 2026JJDCNew Brunswick · $500K – $5M checks · since 2026Johnson & Johnson Innovation – JJDCNew BrunswickNorthpond VenturesBethesda · $100K – $5M checks · since 2026SV Health InvestorsLondon · $1M – $20M checks · since 2026

Co-founders at Mestag

MB
Michael B. BrennerFounder
CB
Chris BuckleyFounder
MCMark Coles
Mark ColesFounder
SRSoumya Raychaudhuri
Soumya RaychaudhuriFounder
DADavid A. Tuveson
David A. TuvesonFounder

Experience

  1. Mestag TherapeuticsChief Executive Officer, Co-Founder & Board Membercurrent2020 — presentCambridge
  2. Biotech CEO SisterhoodMembercurrent2022 — present
  3. SV Health InvestorsVenture Partnercurrent2020 — presentLondon
  4. Gyroscope Therapeutics, acquired by Novartis for $1.5bnChief Business Officer2019London UK / Philadelphia US
  5. Orbit Biomedical, Inc., acquired by Gyroscope 2019Chief Executive Officer2017 — 2019Philadelphia US / London UK
  6. Clipper BiotechFounder & Principal2015 — 2018Geneva, New York, London
  7. Spur TherapeuticsChief Business Officer (Freeline Therapeutics, now Spur Therapeutics)2016 — 2017London
  8. Lysogene TherapeuticsVP Business Development2015 — 2016Paris
  9. Alexion Pharmaceuticals, Inc.Senior Director, Global Business & Corporate Development2013 — 2015Geneva
  10. Merck SeronoHead of Global Portfolio Management, Fertility, Endocrinology & General Medicine2013Geneva
  11. Merck SeronoHead of Global Business Development, Neurodegenerative & Autoimmune Diseases2010 — 2013
  12. Merck HealthcareHead of Global Business Development, Fertility & Endocrinology2008 — 2010
  13. Merck HealthcareDirector Global Business Development2005 — 2008
  14. Aberdeen Asset ManagementWhite Rose Seedcorn Fund2002 — 2005
  15. KPMG Corporate FinanceHealthcare & Consumer Markets1999 — 2002

Skills & more

Start-upsMergersPharmaceutical IndustryBiotechnologyOncologyDrug DiscoveryMergers & AcquisitionsLicensingDrug DevelopmentCommercializationBusiness DevelopmentClinical Trials
+12 moreHealthcareBiopharmaceuticalsEndocrinologyEmerging MarketsLifesciencesClinical DevelopmentCross-functional Team LeadershipStrategyPortfolio ManagementLife SciencesTechnology TransferInvestments

Languages English · French

  • Member of LifeScience ORG — LifeScience ORG
  • previously Fellow of the Securities Institute — Securities Institute, UK

From Susan's professional profile.

Frequently asked questions

Who is Susan Hill?
Founder & Chief Executive Officer at Mestag Therapeutics
Where does Susan Hill work?
Susan Hill is Chief Executive Officer at Mestag.
Where did Susan Hill go to school?
Susan Hill studied at IMD (Strategies for Leadership Program); University of Cambridge (Doctor of Philosophy (PhD), Molecular Biology & Diagnostics); University of Cambridge (Master of Arts (MA), Natural Sciences (focus on Molecular Biology)).

Founder mafias

Same school

Shared employers